Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,400.00    -50.00 (-0.92%)
Bid:
5,300.00
Ask:
5,400.00
Spread: 100.00 (1.887%)
Market Cap: £136.50m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Result of AGM

9 Jun 2023 12:08

RNS Number : 2810C
Camellia PLC
09 June 2023
 

Camellia Plc

Results of Annual General Meeting - 8 June 2023

 

Camellia Plc (the "Company") held its 2023 Annual General Meeting on 8 June 2023. All resolutions were passed. The proxy votes received from shareholders on each resolution are set out below.

 

Resolution

Total Votes* For

Total Votes* Discretionary

Total Votes* Against

Votes* Withheld

1.

To receive the Company's annual accounts and the Directors', strategic and auditors' reports 

1,633,176

(99.74%)

4,082

(0.25%)

208(0.01%)

183

2.

To approve the Directors' remuneration report

1,630,422(99.59%)

4,082

(0.25%)

2,637

(0.16%)

508

3.

To approve the Policy on Directors' remuneration

1,631,567

(99.67%)

4,051

(0.25%)

1,293

(0.08%)

738

4.

To declare a final dividend of 102 pence per ordinary share

1,633,107

(99.72%)

4,051

(0.25%)

491

(0.03%)

0

5.

To re-elect Malcolm Perkins as a Director

1,630,733

(99.69%)

4,051

(0.25%)

1,003

(0.06%)

1,862

6.

To re-elect Graham Mclean as a Director

1,632,400

(99.70%)

4,051

(0.25%)

816

(0.05%)

382

7.

To re-elect Susan Walker as a Director

1,632,349

(99.70%)

4,051

(0.25%)

867

(0.05%)

382

8.

To re-elect Frédéric Vuilleumier as a Director

1,630,998

(99.61%)

4,051

(0.25%)

2,218

(0.14%)

382

9.

To re-elect Simon Turner as a Director

1,630,521

(99.59%)

4,082

(0.25%)

2,664

(0.16%)

382

10.

To re-elect Stephen Buckland as a Director

1,487,373

(90.84%)

4,082

(0.25%)

145,812

(8.91%)

382

11.

To re-elect Rachel English as a Director

1,632,778

(99.73%)

4,082

(0.25%)

407

(0.02%)

382

12.

To re-appoint Deloitte LLP as auditors to the Company

1,633,283

(99.73%)

4,082

(0.25%)

284

(0.02%)

0

13.

To authorise the Directors to determine the auditors' remuneration

1,633,467

(99.74%)

4,082

(0.25%)

100

(0.01%)

0

14.

To authorise the Company to make market purchases of its own ordinary shares

1,632,963

(99.72%)

4,051

(0.25%)

452

(0.03%)

183

 

*Total number of proxy votes received.

 

A "vote withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes against the resolution.

The total voting rights in the Company are 2,762,000.

 

Enquiries

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Amarpal Takk, General Counsel & Company Secretary

 

Panmure Gordon 020 7886 2500 

Nominated Adviser and Broker 

Emma Earl 

Rupert Dearden

Maitland/AMO 07785 292617

PR 

William Clutterbuck

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGFKLFBXQLBBBD
Date   Source Headline
4th Jun 202612:31 pmRNSResult of AGM
22nd May 20267:00 amRNSSale of Chalouni Tea Estate
5th May 20267:00 amRNSFinal Results
7th Apr 20264:19 pmRNSProposed Sale of Chalouni Tea Estate
1st Apr 20267:00 amRNSArtwork Sale and Update on Indian Tea Estate MOU
23rd Feb 20267:00 amRNSTrading Update
23rd Jan 20267:00 amRNSDirectorate change
27th Nov 20257:00 amRNSKakuzi Land Claims
8th Sep 20254:47 pmRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSHalf Year Results
26th Aug 20257:00 amRNSNotice of Half Year Results
4th Jul 20254:30 pmRNSDisposal
13th Jun 20254:01 pmRNSHolding(s) in Company
13th Jun 20252:35 pmRNSHolding(s) in Company
10th Jun 20259:09 amRNSHolding(s) in Company
9th Jun 20254:39 pmRNSHolding(s) in Company 9 June 2025
6th Jun 20257:00 amRNSResult of Tender Offer
5th Jun 20252:02 pmRNSResult of General Meetings
19th May 20257:00 amRNSTender Offer
19th May 20257:00 amRNSValue Enhancement Plan
13th May 20257:00 amRNSHolding(s) in Company
9th May 20257:00 amRNSTransaction in Own Shares
8th May 20257:00 amRNSValue Enhancement Plan Date & Presentation
30th Apr 20257:00 amRNSFinal Results
28th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSTransaction in Own Shares
24th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSPotential Disposal
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares
7th Apr 20259:07 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSDisposal
11th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20257:00 amRNSPotential Disposal
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.